Atlas Trials

Liquid Biopsy Following BBB Disruption Using Barrier Disrupting Fields in Patients Undergoing Spine Surgery

Clinical trial NCT07224451 · RECRUITING

Trial details

NCT number
NCT07224451
Sponsor
Sheba Medical Center
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Spinal Tumors
Start date
2025-10-16
Primary completion
2027-10-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.